Cargando…

Safety assessment of concurrent statin treatment and evaluation of drug interactions in China

OBJECTIVES: Acute muscle injury and potentially fatal rhabdomyolysis may occur with the use of statins and certain enzyme inhibitors, but data on this topic from China are quite limited. This study aimed to measure the concomitant exposure of patients to different statins and their enzyme inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Ming-Ming, Wu, Shu-Shan, Ying, Yin-Qing, Lu, Nan, Zhong, Ming-Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187411/ https://www.ncbi.nlm.nih.gov/pubmed/30345053 http://dx.doi.org/10.1177/2050312118798278

Ejemplares similares

Safety of statins
por: Maji, Debasish, et al.
Publicado: (2013)

Statin drug-drug interactions in a Romanian community pharmacy
por: BADIU, RALUCA, et al.
Publicado: (2016)

Statin‐associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
por: Frasson, Emma, et al.
Publicado: (2021)

Potential statin-drug interactions: prevalence and clinical significance
por: Zhelyazkova-Savova, Maria, et al.
Publicado: (2014)

STATIN INDUCED NECROTIZING AUTOIMMUNE MYOPATHY WITHOUT CONCURRENT STATIN USE: YET ANOTHER SEQUELA OF COVID-19?
por: Jaffry, Hassam, et al.
Publicado: (2022)

Intensive statin versus low-dose statin + ezetimibe treatment for fibrous cap thickness of coronary vulnerable plaques
por: Meng, Pei-Na, et al.
Publicado: (2020)

Soil nutrient assessment based on attribute recognition model in the Loess Plateau of China
por: Jiao, Feng, et al.
Publicado: (2013)

Potential drug interactions with statins: Estonian register-based study
por: Gavronski, Maia, et al.
Publicado: (2015)

Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
por: Zhou, Yi-Ting, et al.
Publicado: (2013)

Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China
por: Lei, Ming, et al.
Publicado: (2018)

Safety and Efficacy of Tirofiban Combined with Statins in the Perioperative Period of Intracranial Aneurysms: Systematic Review and Meta-Analysis
por: Hao, Ming, et al.
Publicado: (2022)

Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE
por: Banach, Maciej, et al.
Publicado: (2021)

Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction
por: Siriangkhawut, Methira, et al.
Publicado: (2017)

Exploring drug combinations in genetic interaction network
por: Wang, Yin-Ying, et al.
Publicado: (2012)

Statin use after intracerebral hemorrhage: a 10‐year nationwide cohort study
por: Tai, Shu‐Yu, et al.
Publicado: (2016)

Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis C
por: Kuo, Meng-Hsuan, et al.
Publicado: (2020)

Statins as antiepileptogenic drugs: Analyzing the evidence and identifying the most promising statin
por: Hufthy, Yousif, et al.
Publicado: (2022)

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review
por: Yow, Hui-Yin, et al.
Publicado: (2023)

Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction
por: Ezad, Saad, et al.
Publicado: (2018)

Genetic interaction networks mediate individual statin drug response in Saccharomyces cerevisiae
por: Busby, Bede P., et al.
Publicado: (2019)

Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)
por: LIU, Yu-Qi, et al.
Publicado: (2021)

Trimetazidine restores the positive adaptation to exercise training by mitigating statin‐induced skeletal muscle injury
por: Song, Ming, et al.
Publicado: (2017)

Effectiveness and Safety of Concurrent Use of First-Line Antiretroviral and Antituberculous Drugs in Rwanda
por: Kadima, Justin Ntokamunda, et al.
Publicado: (2014)

Effect and safety of combination lipid‐lowering therapies based on statin treatment versus statin monotherapies on patients with high risk of cardiovascular events
por: Wang, Chunli, et al.
Publicado: (2018)

The difference between fasting and non-fasting lipid measurements is not related to statin treatment
por: Liu, Ming-Ming, et al.
Publicado: (2021)

Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry
por: Bae, Han Joon, et al.
Publicado: (2020)

Concurrent Use of Conventional Drugs with Chinese Herbal Products in Taiwan: A Population-based Study
por: Chen, Ming-Chen, et al.
Publicado: (2013)

Statins as potential therapeutic drug for asthma?
por: Yuan, Cheng, et al.
Publicado: (2012)

Co-Medication of Statins with Contraindicated Drugs
por: Yang, Bo Ram, et al.
Publicado: (2015)

Drug-drug-gene Interactions as Mediators of Adverse Drug Reactions to Diclofenac and Statins: A Case Report and Literature Review
por: Božina, Nada, et al.
Publicado: (2021)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Kao, Yu-Cheng, et al.
Publicado: (2021)

Statins as Potential Preventative Treatment of ETX and Multiple Pore-Forming Toxin-Induced Diseases
por: Huang, Jing, et al.
Publicado: (2023)

Concurrent Hearing and Genetic Screening among Newborns in Ningbo, China
por: Guomei, Cao, et al.
Publicado: (2022)

Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer
por: Ma, Ning-Yi, et al.
Publicado: (2021)

A prospective study of hepatic safety of statins used in very elderly patients
por: Guo, Meizi, et al.
Publicado: (2019)

Ticagrelor-induced acute kidney injury can increase serum concentration of statin and lead to concurrence of rhabdomyolysis
por: Park, In Seong, et al.
Publicado: (2018)

Assessment of Physician's Knowledge of Potential Drug-Drug Interactions: An Online Survey in China
por: Yuan, Jing, et al.
Publicado: (2021)

Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017)

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting
por: Ezhov, Marat V., et al.
Publicado: (2023)

Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis
por: Tsui, Leo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lhqh0q0gfj9bkjf34120rupa2d